System Transmission

Top Signal

100#1 JOB

Activity

2188Ripe

+949 today

System

Live3m

Terminal Asset View

stockNASDAQ

BMEA

$1.36-3.55%

Biomea Fusion Inc. - Common Stock

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

1Overripe

Live Analysis Active

Synchronizing Data Stream

Establishing multi-vendor link for BMEA

Pipeline Initializing...

System Progress0%

Low Latency Link

Encrypted Port

Company Mission

Biomea Fusion is a biotechnology company that researches and develops new cancer treatments. They create experimental drugs designed to target specific enzymes that help cancer cells grow and survive. The company makes money through research funding, partnerships with larger pharmaceutical companies, and hopes to eventually earn revenue from selling approved medications to hospitals and patients.

BME

Industry Context

Biomea Fusion operates in the biotechnology industry, which focuses on developing new medical treatments through scientific research. This sector is known for high volatility as companies announce clinical trial results, regulatory decisions, and partnership deals that can significantly move stock prices.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

29Matrix

Market Momentum

56.3— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.7x— Normal Volume

Today's Change

-3.55%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing BMEA across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 05:24 PM UTC

As-of 03-14-2026 17:09 UTC

Develops cancer drugs that target specific enzymes and makes money by selling these treatments to hospitals and clinics.

Weekly price swings are getting smaller near recent levels, suggesting the Stock is coiling up for a bigger move soon.

Biotech sector volatility often increases during clinical trial announcements, which could impact this company's Stock price movement.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...